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Summary
 
Evidence accumulated over more than two decades has
implicated Ca
 
2+
 
 dysregulation in brain aging and Alzheimer’s
disease (AD), giving rise to the Ca
 
2+
 
 hypothesis of brain
aging and dementia. Electrophysiological, imaging, and
behavioral studies in hippocampal or cortical neurons of
rodents and rabbits have revealed aging-related increases
in the slow afterhyperpolarization, Ca
 
2+
 
 spikes and currents,
Ca
 
2+
 
 transients, and L-type voltage-gated Ca
 
2+
 
 channel (L-
VGCC) activity. Several of these changes have been asso-
ciated with age-related deficits in learning or memory.
Consequently, one version of the Ca
 
2+
 
 hypothesis has been
that increased L-VGCC activity drives many of the other
Ca
 
2+
 
-related biomarkers of hippocampal aging. In addition,
other studies have reported aging- or AD model-related
alterations in Ca
 
2+
 
 release from ryanodine receptors
(RyR) on intracellular stores. The Ca
 
2+
 
-sensitive RyR channels
amplify plasmalemmal Ca
 
2+
 
 influx by the mechanism of
Ca
 
2+
 
-induced Ca
 
2+
 
 release (CICR). Considerable evidence
indicates that a preferred functional link is present between
L-VGCCs and RyRs which operate in series in heart and some
brain cells. Here, we review studies implicating RyRs in
altered Ca
 
2+
 
 regulation in cell toxicity, aging, and AD. A recent
study from our laboratory showed that increased CICR plays
a necessary role in the emergence of Ca
 
2+
 
-related biomarkers
of aging. Consequently, we propose an expanded L-VGCC/
Ca
 
2+
 
 hypothesis, in which aging/pathological changes occur
in both L-type Ca
 
2+
 
 channels and RyRs, and interact to
abnormally amplify Ca
 
2+
 
 transients. In turn, the increased
transients result in dysregulation of multiple Ca
 
2+
 
-dependent
processes and, through somewhat different pathways, in
accelerated functional decline during aging and AD.
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Introduction
 
It has been over 20 years since it was initially proposed that
altered Ca
 
2+
 
 regulation might play a role in brain aging and
Alzheimer’s disease (AD) (Landfield, 1983, 1987; Khachaturian,
1984, 1989; Gibson & Peterson, 1987; Disterhoft 
 
et al
 
., 1994).
In brain neurons from aging rodents and rabbits, as compared
to neurons from younger animals, Ca
 
2+
 
 influx associated with
action potentials induces a larger Ca
 
2+
 
-dependent afterhyper-
polarization (AHP) (Landfield & Pitler, 1984; Kerr 
 
et al
 
., 1989;
Moyer 
 
et al
 
., 1992; Potier 
 
et al
 
., 1992; Disterhoft 
 
et al
 
., 1996,
2004; Stutzmann 
 
et al
 
., 2006) and impairs short-term synaptic
plasticity (Landfield 
 
et al
 
., 1986; Thibault 
 
et al
 
., 2001). Further-
more, these findings have been reinforced by studies showing
that pharmacologically isolated Ca
 
2+
 
 action potentials (Pitler &
Landfield, 1990; Disterhoft 
 
et al
 
., 1996), whole-cell Ca
 
2+
 
 currents
(Campbell 
 
et al
 
., 1996), and Ca
 
2+
 
 transients during repetitive
spike trains also are larger in hippocampal neurons from aged
animals (Thibault 
 
et al
 
., 2001; Hemond & Jaffe, 2005). Conversely,
Ca
 
2+
 
 influx via ligand-gated N-methyl-D-aspartate (NMDA)
receptor channels appears reduced in aged animals (Barnes 
 
et al
 
.,
1997; Magnusson, 1998; Shankar 
 
et al
 
., 1998).
Our studies on this general Ca
 
2+
 
 dysregulation hypothesis
have focused primarily on apparent excess Ca
 
2+
 
 influx via
voltage-gated Ca
 
2+
 
 channels (VGCC) (Landfield, 1996; Thibault
 
et al
 
., 1998). Studies of the L-type VGCC (L-VGCC) antagonist
suggested that the aging-related increase in Ca
 
2+
 
-mediated
responses might depend on greater activity through L-VGCC
(Moyer 
 
et al
 
., 1992; Campbell 
 
et al
 
., 1996). Increased L-VGCC
activity with aging was confirmed directly by single channel
recording in partially dissociated hippocampal slices (Thibault &
Landfield, 1996). Moreover, changes in L-VGCCs appear to be
functionally relevant, as L-VGCC antagonists improve learning
and memory in aged animals (Deyo 
 
et al
 
., 1989; Disterhoft 
 
et al
 
.,
2004) and some AD patients (Forette 
 
et al
 
., 2002). Furthermore,
the increase in L-VGCC density is positively correlated with
cognitive impairment in aged animals (Thibault & Landfield, 1996).
In addition to the accumulating evidence of increased Ca
 
2+
 
influx through L-VGCCs, there is also recent evidence that
altered function of intracellular organelles might play a critical
role in Ca
 
2+
 
 regulation during aging or AD (Toescu & Verkhrat-
sky, 2003). In particular, changes in intracellular Ca
 
2+
 
 release
from the endoplasmic reticulum (ER) appear likely to contribute
to brain Ca
 
2+
 
 dyshomeostasis, and have been associated with
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changes in [Ca
 
2+
 
]
 
i
 
. Therefore, in this review, we summarize several
lines of evidence implicating altered release from intracellular
stores in aging and AD, and attempt to integrate this evidence
with the role of Ca
 
2+
 
 influx in aging-related Ca
 
2+
 
 dysregulation.
 
Interactions between L-VGCCs and Ca
 
2+
 
-
induced Ca
 
2+
 
 release from the endoplasmic/
sarcoplasmic reticulum
 
Several comprehensive reviews have recently considered
mechanisms associated with Ca
 
2+
 
 sequestration and release by
the ER in both peripheral cells (Bootman 
 
et al
 
., 2001; Berridge,
2002; Carafoli, 2002; Fill & Copello, 2002) and in neurons
(Paschen & Mengesdorf, 2005; Verkhratsky, 2005). Accordingly,
only the points most relevant to ER function in brain aging are
briefly recapitulated here. Two distinct intracellular Ca
 
2+
 
 release
channels are present in several types of muscle and brain cells,
the inositol 1,4,5-trisphospate receptor (IP
 
3
 
R) and the ryanodine
receptor (RyR), each having multiple isoforms in different tis-
sues. These receptor channels function to amplify or trigger Ca
 
2+
 
rises initiated by either plasmalemmal Ca
 
2+
 
 influx or ligand bind-
ing, thereby inducing Ca
 
2+
 
 signaling cascades. Amplification is
achieved through either the actions of Ca
 
2+
 
-induced Ca
 
2+
 
release (CICR), provided by RyR, or actions of IP
 
3
 
-induced Ca
 
2+
 
release (IICR) through IP
 
3
 
Rs.
Originally described in skeletal and cardiac muscle cells, RyRs
in the membrane of the sarcoplasmic reticulum are an integral
and essential Ca
 
2+
 
 source for excitation-contraction coupling
(Endo, 1977; Fill 
 
et al
 
., 1989; Takeshima 
 
et al
 
., 1989; Meissner,
1994). Furthermore, an apparent direct physical interaction,
which favors alignment between L-VGCCs and RyRs, enables
L-VGCCs to function as a preferred source of extracellularly
derived Ca
 
2+
 
 in triggering CICR from RyRs and amplifying Ca
 
2+
 
transients (Lu 
 
et al
 
., 1994; Cheng 
 
et al
 
., 1996; Wang 
 
et al
 
., 2001).
In the brain, similar Ca
 
2+
 
 amplification functions of RyRs have
been identified, again mediated in part by a close juxtaposition
to L-VGCCs (Chavis 
 
et al
 
., 1996; Empson & Galione, 1997;
Borde 
 
et al
 
., 2000; Fagni 
 
et al
 
., 2000; Sukhareva 
 
et al
 
., 2002).
The other major source of intracellular Ca
 
2+
 
 occurs in response
to stimulation of IP
 
3
 
Rs by IP
 
3
 
 generated from activation of a
number of metabotropic G-protein-coupled receptors. In some
cases IP
 
3
 
Rs can also trigger Ca
 
2+
 
-sensitive K
 
+
 
 channels and
hyperpolarize neurons (Sawada 
 
et al
 
., 1987; Fink 
 
et al
 
., 1988;
Furuichi 
 
et al
 
., 1989; Zhang 
 
et al
 
., 1990; Berridge, 1993;
Khodakhah & Ogden, 1995; Irving & Collingridge, 1998;
Taylor 
 
et al
 
., 1999; Johenning 
 
et al
 
., 2002; Rossi & Taylor,
2004). Moreover, IP
 
3
 
Rs are also sensitive to Ca
 
2+
 
 concentrations
(Bezprozvanny 
 
et al
 
., 1991; Missiaen 
 
et al
 
., 1992; Tsukioka 
 
et al
 
.,
1994; Hagar 
 
et al
 
., 1998) and, depending on the cell type studied,
it appears that IP
 
3
 
R may also be favorably aligned with L-VGCCs
or metabotropic glutamate receptors (mGluR), through inter-
actions with the scaffold protein Homer 1a (Tu 
 
et al
 
., 1998; Fagni
 
et al
 
., 2000; Yamamoto 
 
et al
 
., 2005).
Release of Ca
 
2+
 
 from these two intracellular channels is
regulated in part by the Ca
 
2+
 
 concentration gradient present
between luminal ER Ca
 
2+
 
 and cytoplasmic Ca
 
2+
 
 (Alonso 
 
et al
 
.,
1999; Kiryushko 
 
et al
 
., 2002; Solovyova 
 
et al
 
., 2002) and is, thus,
also dependent on the Ca
 
2+
 
-refilling function of sarcoplasmic/
endoplasmic reticulum Ca
 
2+
 
-ATPases (SERCA). Sarcoplasmic/
endoplasmic reticulum Ca
 
2+
 
-ATPases maintain the relatively
high levels of Ca
2+ in the ER (hundreds of µM) that serve CICR,
and IICR, and, in the process, contribute to the control and
reduction of cytosolic Ca
2+ (Thastrup et al., 1990; MacLennan
et al., 1997; Mogami et al., 1998; Meldolesi, 2001; Berridge,
2002; Verkhratsky, 2004).
Dysregulated Ca
2+ and ER function in models 
of ischemia and toxicity
Although cell culture models of Ca
2+-dependent cell death are
generally not viewed as clear models of brain aging, or even
AD, they are often employed in studies of ischemic events.
These events increase in frequency with advancing age, and it
is also possible that neuronal vulnerability from such events
increases with aging. Therefore, examining the role of Ca
2+
release from intracellular stores in cell death models may help
elucidate implications of aging-related alterations in intracellular
release. In particular, delayed toxicity after exposure to high
glutamate (GLU) in cell culture (excitotoxicity) is a common
model used to mimic a wide range of neurological insults,
including anoxia/ischemia, head and spinal cord trauma, and even
chronic neurodegenerative diseases such as AD. Dysregulated
Ca
2+ homeostasis and altered Ca
2+ influx through NMDA receptors
were identified as primary contributors to neuronal cell death
early in the study of excitotoxicity (Rothman & Olney, 1986;
Choi et al., 1987; Wahl et al., 1989; Regan & Choi, 1991;
Randall & Thayer, 1992; Dubinsky, 1993; Lu et al., 1994; Marks
et al., 1996; Tymianski & Tator, 1996; Toescu, 1998; Lee et al.,
1999; Limbrick et al., 2001; Lipton, 2004). In excitotoxicity mod-
els, Ca
2+ dysregulation is frequently manifested as an irreversible
Ca
2+ rise or slowed Ca
2+ clearance, and is ultimately associated
with neuronal death.
Several investigations of excitotoxicity have focused on a
potential role of the ER in sustained Ca
2+ elevations. These studies
have found that blocking CICR with high concentrations of
ryanodine, which lock RyRs in a low conductance state
(Bezprozvanny et al., 1991; Coronado et al., 1994; Humerickhouse
et al., 1994), or irreversibly inhibiting SERCA function and pas-
sively emptying ER stores with thapsigargin prior to GLU expo-
sure, reduces sustained Ca
2+ plateaus, as well as other indices
associated with neuronal cell death (e.g. lactate dehydrogenase
(LDH) release) (Frandsen & Schousboe, 1991; Segal & Manor,
1992; Leski et al., 1999; Clodfelter et al., 2002). Similar results
have been noted in models of stroke and ischemia, particularly
in astrocyte preparations (Duffy & MacVicar, 1996; Kuwabara
et al., 1996; Verkhratsky et al., 1998; Aley et al., 2006). Some-
what paradoxically, while short-term ER Ca
2+ depletion prior to
an insult appears protective against necrotic (excitotoxic) cell death,
long-term depletion of ER Ca
2+ induces apoptosis, as indicated by
elevations of apoptotic markers, stress responses and disturbanceCa
2+ stores and the Ca
2+ hypothesis of brain aging, O. Thibault et al.
© 2007 The Authors
Journal compilation © Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland 2007
309
in protein synthesis, and/or massive cell death (Doutheil et al.,
1999; Mengesdorf et al., 2001; Verkhratsky & Petersen, 2002;
Paschen, 2003; Verkhratsky & Toescu, 2003; Lindholm et al., 2006).
Thus, excessive release of Ca
2+ from the ER may play an
important role in excitotoxicity. Moreover, evidence suggests
that such excessive release may be dependent on the relative
maturity of the cells. It is well established that embryonic cortical/
hippocampal neurons become increasingly vulnerable to GLU
toxicity after a few weeks in culture (Choi, 1992; Toescu &
Verkhratsky, 2000), an age in culture that coincides with the
emergence of sustained Ca
2+ plateaus following GLU insult
(Attucci  et al., 2002). Interestingly, ryanodine is particularly
effective in reversing the Ca
2+ plateau and in providing neuro-
protection in older cultures (Fig.  1) (Clodfelter et al., 2002).
Moreover, recent evidence suggests that the lethal Ca
2+ plateau
may be maintained by sustained Ca
2+ influx via depolarized
NMDA receptors (Norris et al., 2006). Together, these data indi-
cate that the plateau may be sustained by CICR. Although age
in culture is clearly not equivalent to brain aging, it is associated
with increasing vulnerability and Ca
2+ influx, which may model
some aspects of normal aging (Porter et al., 1997). Conceivably
therefore, if Ca
2+ release from ER is altered with aging, this alter-
ation may develop in parallel with altered Ca
2+ influx (Clodfelter
et al., 2002).
Ca
2+ release from ER in models of AD
With the increasing development of transgenic (Tg) mouse
models of AD, numerous studies testing the view that altered
Ca
2+ homeostasis might play a role in AD have recently emerged.
Initial studies in fibroblasts from AD patients (Gibson et al.,
1996) or in cells bearing the human presenilin 1 (PS1) AD muta-
tion (Begley et al., 1999; Guo et al., 1999; Leissring et al., 1999;
LaFerla, 2002; Stutzmann, 2005) found evidence of abnormal
Ca
2+ release through IP3R pathways (Leissring et al., 1999).
Interestingly, abnormal IP3-mediated Ca
2+ elevations in fibroblasts
have also been seen in asymptomatic members of AD families
(Etcheberrigaray et al., 1998).
Several studies also have implicated RyRs as being responsible
for enhanced intracellular release in PS1 mutated animals
(Chan et al., 2000; Mattson et al., 2000; Schneider et al., 2001;
Popescu & Ankarcrona, 2004; Stutzmann et al., 2006). Smith
and colleagues (2005) examined cultured cortical neurons from
mice bearing a transgene containing three AD-related muta-
tions (3×Tg mice), which develop both plaques and tangles, and
observed an increase in RyR expression along with greater Ca
2+
efflux from the stores in response to caffeine (an agonist at the
RyR) (Smith et al., 2005). A recent study combining electro-
physiological and Ca
2+ imaging methods in cortical slice neurons
from Tg mice bearing the PS1 mutation alone, or the 3×Tg trans-
gene, or nontransgenic control animals, assessed the effects of
aging vs. those of the PS1 mutation on ER release (Stutzmann
et al., 2006). This study found that the PS1 mutation is a critical
calciopathic mutation and that increased RyR expression is likely
a major factor in the AD mutation-mediated enhancement of
ER release. Although photolysis of IP3 was shown to evoke larger
Ca
2+ transients and Ca
2+-dependent hyperpolarizations in Tg
mice, the increase in IP3 effects was mediated by CICR from RyRs,
triggered in response to IICR. However, some puzzling results also
were seen. The enhanced IP3-mediated Ca
2+ release and resulting
Fig. 1 Ryanodine protection of older cultured hippocampal neurons from excitotoxicity. Following a glutamate insult, older cultured neurons exhibit a sustained 
[Ca
2+]i elevation leading to cell death. Confocal indo-1 Ca
2+ imaging shows ryanodine facilitated the recovery (decline) of the Ca
2+ plateau and protected older 
neurons following glutamate insult (modified from Clodfelter et al. copyright 2002 with permission from Elsevier).Ca
2+ stores and the Ca
2+ hypothesis of brain aging, O. Thibault et al.
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hyperpolarization was larger in Tgs than in non-Tgs at all ages
and did not change with aging in any Tg or non-Tg model. Con-
versely, the AHP induced by trains of spikes and VGCC activa-
tion increased with aging in all three model strains but did not
differ between Tg and non-Tg mice (Stutzmann et al., 2006).
While little is known regarding underlying mechanisms, it
appears that altered CICR, perhaps in combination with IICR,
confer some of the phenotypes of disrupted Ca
2+ homeostasis
in neurons from 3×Tg mice. Still, other sources and mechanisms
likely also contribute. The PS1 mutation (which, alone, does not
induce amyloid plaques), in combination with amyloid precursor
protein (APP) mutations, increases Aβ production (Mullan &
Crawford, 1993; Price & Sisodia, 1994; Tanzi et al., 1996;
Holcomb et al., 1998; Selkoe, 1998). Some studies have found
that Aβ production can exacerbate Ca
2+ responses to NMDA
or GLU exposure (Mattson, 1997). Furthermore, Aβ toxicity has
been attributed, in part, to effects on VGCCs (Davidson et al.,
1994; Weiss et al., 1994; Ueda et al., 1997; Ramsden et al., 2002;
Bobich et al., 2004; Webster et al., 2006), which could trigger
CICR from IP3Rs or RyRs (Koizumi et al., 1998; Ferreiro et al., 2004).
However, APP proteolysis (γ-secretase activity) alone does not
appear sufficient, because the PS1 mutation (rather than other
more amyloidogenic mutations) must be present for the Ca
2+
dysregulation to occur (Stutzmann et al., 2006). A possible
alternative mechanism suggests that presenilins form Ca
2+ leak
channels in ER membranes of mouse fibroblasts, independently
of γ-secretase activity. Mutations in presenilin interfere with this
leak function, and result in greater Ca
2+ filling and release from ER
(Tu et al., 2006). Furthermore, a gene microarray study con-
ducted in autopsied hippocampal tissue from human AD patients
(Blalock et al., 2004) found that multiple genes encoding pro-
teins involved in ER receptor function, or in protein folding and
chaperoning, which are also mediated in part by the ER, were
down-regulated in incipient AD. These widespread changes may
reflect ER membrane/receptor instability in sporadic AD as well.
In addition, it should be noted that effects of PS1 mutations
on Ca
2+ dysregulation have been observed to occur via other
processes, including capacitative Ca
2+ entry (Yoo et al., 2000;
Smith et al., 2002; Herms et al., 2003; Zatti et al., 2006), changes
in mitochondrial potential (Begley et al., 1999; Ankarcrona &
Hultenby, 2002; Chan et al., 2002; Behbahani et al., 2006), and
L-VGCCs (Cook et al., 2005). Clearly therefore additional work
will be needed to resolve the relative contributions of the dif-
ferent sources to the Ca
2+dysregulation seen in various models
of neurodegenerative diseases.
Neuronal ER release in normal aging
Electrophysiological markers of brain aging have been exten-
sively characterized in the hippocampal formation (Landfield &
Pitler, 1984; Moyer et al., 1992; Barnes, 1994; Thibault et al., 1998;
Norris et al., 1998; Disterhoft et al., 2004; Burke & Barnes, 2006),
a region well-established to be important for memory processes
and highly vulnerable to deleterious/degenerative changes with
aging. Many of the consistent biomarkers of aging, such as the
slow AHP (sAHP), are Ca
2+-dependent or Ca
2+-mediated.
However, it is important to assess the degree to which the ER
contributes to the established biomarkers of aging. Both CICR
and IICR pools exist within the ER of hippocampal CA1 and CA3
pyramidal neurons. The amount of Ca
2+ released via CICR and
IICR depends on binding of intracellular ligands including Ca
2+,
cyclic ADP ribose (cADPR), nicotinic acid adenine dinucleotide
phosphate (NAADP) or IP3 (Verkhratsky, 2005), and also
depends on the Ca
2+ sequestering capacity of the ER, which
determines ER Ca
2+ content ([Ca
2+]L) (Verma et al., 1992;
Murayama & Ogawa, 1996; Dawson, 1997; Garaschuk et al.,
1997). Solovyova and colleagues using a dual indicator loading
technique (low affinity indicator for imaging Ca
2+ in the ER, and
high affinity indicator for imaging Ca
2+ in the cytosol) were able
to show that the resting [Ca
2+]L in sensory neurons is in the
range of 200–300 µM, and high concentrations of IP3 or caffeine
result in approximately a 40% decrease in luminal Ca
2+ (Solovyova
et al., 2002). Depolarization induced [Ca
2+]L release was less
effective, ranging from 5 to 30 µM. Other techniques for imag-
ing Ca
2+ within the ER include the use of aequorin or cameleons.
However, there are limitations with these techniques, as the
Ca
2+ reporting proteins must be genetically engineered and
selectively targeted to the ER (Miyawaki et al., 1997; Alonso
et al., 1998; Solovyova & Verkhratsky, 2002). In addition, they
require long incubation times for transfecting and loading and,
thus, preclude their use in acute brain slices.
Consequently, there have been only a handful of studies in
neurons examining the effects of aging on ER Ca
2+ concentra-
tion and release, or on RyR expression. Studies focusing on
measures of ER Ca
2+ content have generally relied on the use
of single wavelength indicators to measure changes in [Ca
2+]i
transients activated by caffeine, and have found varying results,
depending on the experimental approach or preparation. In an
early study, no net change in ER Ca
2+ release with aging was
reported in synaptosomes from the whole brain (Martinez-
Serrano et al., 1992). More recently, acute dissociation of several
brain regions (cerebellar, basal forebrain, and hippocampal
neurons) from aged animals found that CICR magnitude was
reduced and that Ca
2+ transients recovered more slowly
(Verkhratsky  et al., 1994; Kirischuk & Verkhratsky, 1996;
Murchison & Griffith, 1999; Xiong et al., 2002; Alshuaib et al.,
2006). In studies focusing on RyR expression, no clear pattern
or consistent changes have been seen in neurons of normal
aging rats and mice. Two studies reported no change in brain
RyR expression during aging (Martini et al., 1994; Stutzmann
et al., 2006), although a recent study of peripheral neurons
found a transient elevation in protein levels (RyR3) in mid-aged
rats (Vanterpool et al., 2006).
Another approach to the investigation of the possible role of
the ER in brain aging is to examine the effects of aging on Ca
2+-
dependent processes that are modulated, in part, by intra-
cellular Ca
2+ release. In CA1 neurons, postsynaptic injection of
IP3 or of RyR inhibitors prevents the induction of long-term poten-
tiation and attenuates paired-pulse facilitation (Wang & Kelly,
1997). Similarly, bath application of thapsigargin or cyclopiazonicCa
2+ stores and the Ca
2+ hypothesis of brain aging, O. Thibault et al.
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acid (blockers of SERCA) prevents the induction of long-term
depression in both single neurons and in field potential meas-
ures (Reyes & Stanton, 1996). High concentrations of ryanodine
also selectively reduce the sAHP and spike-frequency accom-
modation (Borde et al., 2000; Shah & Haylett, 2000). While
examining the effect of aging on long-term depression induc-
tion (Norris et al., 1998), Foster and colleagues recently reported
that cyclopiazonic acid, thapsigargin or ryanodine (agents that
reduce CICR) all prevented long-term depression in aged neu-
rons (Kumar & Foster, 2005). However, long-term potentiation,
which tends to be decreased with aging (Burke & Barnes, 2006),
was enhanced by high ryanodine concentrations in aged slices
(Kumar & Foster, 2004). Ca
2+-dependent processes mediated
largely by IICR and mGluRs activation also have been shown to
change with aging. Compared to younger animals, type 1
mGluR activation results in a reduced phosphoinositide turnover
in aged rats, perhaps mediated by a reduction in phospholipase
C activity (Nicolle et al., 1999). Similarly, protein kinase C (PKC)
was also reported to show reduced activity in aging neurons
(Araki et al., 1994; Pascale et al., 1998).
Thus, the evidence on the nature of altered CICR or IICR in
neurons of normally aging mammals is somewhat inconsistent,
perhaps reflecting the type of preparation, cell or brain region
specificity, or the difficulty in imaging Ca
2+ and its sources within
the intact hippocampal slice (Brown & Jaffe, 1994). Recently
therefore we sought to systematically test the contributions of
CICR to aging changes in one of the brain regions studied most
extensively in relation to aging (hippocampus). Specifically,
we tested the key prediction that, if increased CICR plays a
major role in normal brain aging, then blocking it with high
concentration ryanodine should reduce the aging differences
in multiple Ca
2+ biomarkers of aging.
More broadly, in fact, several other important tenets of the
overall Ca
2+ hypothesis have, for some time, required adequate
testing. These tenets and predictions include: (i) if a common
mechanism of Ca
2+ dysregulation underlies many aspects of
brain aging, then multiple Ca
2+-dependent biomarkers of aging
in the hippocampus should emerge at approximately the same
age in adulthood; and (ii) if Ca
2+ dysregulation is a major factor
in cognitive decline then Ca
2+ biomarkers should precede or
Fig. 2 Ryanodine reduces the slow 
afterhyperpolarization (AHP) in an age-dependent 
manner. (A) Representative example of the 
blocking effect of 20 µM ryanodine on the AHP 
of a 23-month-old rat CA1 neuron. (B) Age 
dependence of slow AHP (sAHP) amplitude, before 
and following ryanodine application. (C) Age 
dependence of slow AHP duration, pre- and 
postryanodine. (D) Age dependence of medium 
AHP (mAHP) amplitude, pre- and postryanodine. 
(E) Age-dependence measures of spike-frequency 
accommodation, pre- and postryanodine. * 
indicates a significant difference from the 
4-month-old group (P < 0.05). Note that aging 
changes in sAHP markers emerge at 12 months 
of age (preryanodine group), and ryanodine 
completely eliminates the aging effects (B and C), 
indicating a selective blockade of the aging-related 
increase in Ca
2+-induced Ca
2+ release (CICR). The 
initial mAHP is not modulated by CICR (A) and its 
age dependence was not altered by ryanodine (D). 
Action potential accommodation changes 
generally followed the sAHP pattern, but the aging 
effect at 12 months was not significant in this 
subset of cells (mean ± SEM) (from Gant et al. 
copyright 2006 with permission from the Society 
for Neuroscience).Ca
2+ stores and the Ca
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coincide with the earliest age of cognitive impairment, which
in some studies of rats has been as early as 12-months old
(approximately mid-life). To test these predictions and the
involvement of CICR on the emergence of Ca
2+-related biomarkers,
we recently conducted an extensive age course study combining
electrophysiological and Ca
2+ imaging techniques in hippocampal
slices from male rats. Animals at five age points were used to
identify the age of onset for three Ca
2+-mediated markers of
aging, the sAHP, spike accommodation, and the synaptically
activated Ca
2+ transient. A subset of hippocampal slices received
a high dose of ryanodine to block the contribution of CICR to
the overall Ca
2+ response. In this study, we also employed the least
invasive procedures available (sharp intracellular electrodes
instead of patch clamping electrodes, nondissociated slices) to
minimize interactions of preparation trauma and age.
Results were consistent with the above predictions. That is,
ryanodine essentially eliminated aging differences in the three
markers (e.g. the sAHP, Fig. 2), and the three biomarkers were
first detectable simultaneously and at 12 months of age (Fig. 2),
an age range early enough to account for cognitive decline. The
ryanodine-sensitive component of the Ca
2+ response (i.e. CICR)
during a 20-s train of synaptic spikes appears to be minimal in
young neurons compared to aged neurons and, notably, CICR
contributed most to the [Ca
2+]i elevation during the first few
seconds of the train (Fig. 3). This rapid ‘booster’ action of CICR
on Ca
2+ responses is consistent with its strong effect on the AHP
(Fig. 2) (Gant et al., 2006).
Thus, results of this large study provide considerable support
for the proposition that in the hippocampus, an aging-related
increase in CICR is necessary, from the onset, for the development
of aging changes in several Ca
2+-related processes. Moreover,
the findings may help to resolve some of the contradictions in
the literature by elucidating the conditions under which the con-
tributions of CICR are most prominent. However, one apparent
paradox is that similar kinds of evidence support a critical role
for L-VGCCs in aging-related Ca
2+ dysregulation (Thibault et al.,
1998; Disterhoft et al., 2004). Nevertheless, these two lines of
evidence are not necessarily contradictory, given that L-VGCCs
and RyRs appear to operate in series in many cell types. In this
view, then, Ca
2+ influx via L-VGCCs may be the preferred
source for triggering elevated CICR in aging. Together, the data
suggest that aging changes in both types of channel may be
part of the same pathway of dysregulation, in turn, suggesting
the utility of expanding this version of the Ca
2+ hypothesis to
incorporate the results on Ca
2+ release from intracellular stores
(Fig. 4).
Conclusions and a new model of Ca
2+ 
dysregulation in hippocampal aging
The work summarized above points to the following basic
conclusions:
1 Extensive evidence supporting the hypothesis that Ca
2+ dys-
regulation contributes in part to brain aging and AD that has
accumulated for more than 20 years, some of it implicating a
larger Ca
2+-dependent AHP and increased activity of L-type Ca
2+
Fig. 3 Ryanodine-sensitive component of the [Ca
2+]i rise during repetitive 
synaptic stimulation. Ca
2+-induced Ca
2+ release (CICR) contribution to the 
[Ca
2+]i rise was determined by subtracting [Ca
2+]i measures following ryanodine 
from those before ryanodine application (∆[Ca
2+]i), in neurons from 4- and 
23-month-old animals during 20-s trains of 7 Hz suprathreshold synaptic 
stimulation. Values shown represent only the (CICR) component of the Ca
2+ 
response that was blocked by ryanodine. Note that the ryanodine-sensitive 
component of [Ca
2+]i is significantly greater in aged rat neurons and contributes 
to the Ca
2+ response primarily during the first 5 s of stimulation. * indicates 
a significant difference from the 4-month-old group (P < 0.05). (mean ± SEM).
Fig. 4 Schematic model of alterations in L-type voltage-gated Ca
2+ channels 
(L-VGCC) and Ca
2+-induced Ca
2+ release (CICR) that drive other Ca
2+-related 
hippocampal biomarkers of aging. With aging, increased L-VGCC activity and 
enhanced CICR operate in series, amplifying the impact of Ca
2+ influx on 
multiple Ca
2+-dependent functions. The thickness of arrows schematically 
represents the activity of Ca
2+ flux or signaling pathways in aged rat neurons 
(B) relative to young (A). These pathways are increased at several stages 
despite equivalent spike amplitudes and durations. Dashed arrows indicate 
a possible direct parallel contribution of L-VGCCs to [Ca
2+]i (From Gant et al. 
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channels in the functional and cognitive decline seen with normal
aging in mammals.
2 Elevated Ca
2+ release from RyRs appears to contribute import-
antly to cell death and vulnerability in several models of toxicity,
which may have relevance to aging-associated ischemic events
or other degenerative conditions.
3 Some types of AD mutations (e.g. presenilins), but not all,
appear to alter RyR expression. Under some conditions, (e.g. IP3
stimulation and consequent CICR), this can result in elevated
intracellular Ca
2+ release and greater hyperpolarization of
cortical neurons from transgenic mice of all ages. Surprisingly,
however, in the triple transgenic AD model, the aging-related
increase in spike train-induced AHP did not differ from the aging
change in the AHP seen in wild-type mice.
4 The observed contributions of altered CICR to Ca
2+ dysregu-
lation in neurons during normal aging have been somewhat
inconsistent, apparently depending, in part, on cell type and
preparation, regional localization and possibly species. However,
our recent studies in hippocampal slices from rats of increasing
age (five age points) indicate that elevated CICR, beginning at
about 12 months of age, may be an important underlying factor
in the emergence of multiple Ca
2+-related biomarkers of brain
aging in rats.
5 The apparent strong evidence linking both L-VGCCs and
RyRs to dysregulated hippocampal Ca
2+ homeostasis during
aging, rather than being contradictory, may instead suggest an
expanded model of the Ca
2+ dysregulation pathway in brain
aging and, perhaps in AD (as shown in Fig.  4). In this new
model, L-VGCCs and RyRs operate in series and aging changes
in both (or either) contribute to the aberrant amplification of
Ca
2+ transients.
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